These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 709092)

  • 1. Low-cholesterol diet: enhancement of effect of CDCA in patients with gall stones.
    Maudgal DP; Bird R; Blackwood WS; Northfield TC
    Br Med J; 1978 Sep; 2(6141):851-3. PubMed ID: 709092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sodium acetyl salicylate on cholesterol saturation of fasting gall bladder bile, with and without chenic acid.
    Kupfer RM; Northfield TC
    Br J Clin Pharmacol; 1983 Jan; 15(1):114-6. PubMed ID: 6849734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones.
    Iser JH; Maton PN; Murphy GM; Dowling RH
    Br Med J; 1978 Jun; 1(6126):1509-12. PubMed ID: 656777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleation time of gall bladder bile in gall stone patients: influence of bile acid treatment.
    Sahlin S; Ahlberg J; Angelin B; Reihnér E; Einarsson K
    Gut; 1991 Dec; 32(12):1554-7. PubMed ID: 1773966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption.
    Ponz de Leon M; Carulli N; Loria P; Iori R; Zironi F
    Gastroenterology; 1979 Aug; 77(2):223-30. PubMed ID: 447035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin in gall bladder bile of gall stone patients: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.
    Sahlin S; Danielsson A; Angelin B; Reihnér E; Henriksson R; Einarsson K
    Gut; 1988 Nov; 29(11):1506-10. PubMed ID: 3209106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal timing of doses of chenic acid in patients with gall stones.
    Maudgal DP; Bird R; Northfield TC
    Br Med J; 1979 Apr; 1(6168):922-3. PubMed ID: 435882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vivo dissolving of gall-stones: the effect of chenodeoxycholic acid. (author's transl)].
    Fromm H; Eschler A; Töllner D; Canzler H; Schmidt FW
    Dtsch Med Wochenschr; 1975 Aug; 100(32):1619-24. PubMed ID: 170051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of clofibrate-induced cholesterol oversaturation of bile with chenodeoxycholic acid.
    Bateson MC; Ross PE; Murison J; Bouchier IA
    Br Med J; 1978 May; 1(6121):1171-3. PubMed ID: 638677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-cholesterol diet in patients with gall stones taking chenodeoxycholic acid.
    Watts JM; Down RH; Whiting MJ
    Br Med J; 1979 Jan; 1(6157):200. PubMed ID: 421027
    [No Abstract]   [Full Text] [Related]  

  • 11. Diet and gall stones: effects of refined and unrefined carbohydrate diets on bile cholesterol saturation and bile acid metabolism.
    Thornton JR; Emmett PM; Heaton KW
    Gut; 1983 Jan; 24(1):2-6. PubMed ID: 6293939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting gall-stone dissolution rate during chenic acid therapy.
    Maudgal DP; Kupfer RM; Northfield TC
    Gut; 1983 Jan; 24(1):7-10. PubMed ID: 6848433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diurnal variation in cholesterol saturation of gall-bladder bile.
    Kupfer RM; Northfield TC
    Gut; 1983 Oct; 24(10):950-3. PubMed ID: 6684613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?
    Iser JH; Murphy GM; Dowling RH
    Gut; 1977 Jan; 18(1):7-15. PubMed ID: 838406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet.
    Maudgal DP; Kupfer RM; Northfield TC
    Gut; 1982 Apr; 23(4):280-4. PubMed ID: 7076005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prolonged feeding with chenodeoxycholic acid on bile in patients with and without gallstones.
    Bateson MC; Ross PE; Murison J; Bouchier IA
    Gut; 1977 Aug; 18(8):599-605. PubMed ID: 330352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of obesity and weight reduction on biliary cholesterol saturation and the response to chenodeoxycholic acid.
    Reuben A; Qureshi Y; Murphy GM; Dowling RH
    Eur J Clin Invest; 1986 Apr; 16(2):133-42. PubMed ID: 3089808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criteria for selection of patients for medical treatment (chenodeoxycholic acid therapy) of gallstones.
    Bruusgaard A; Malver E; Pedersen LR; Schlichting P; Sylvest J
    Scand J Gastroenterol; 1977; 12(1):97-102. PubMed ID: 834976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimum bile acid treatment for rapid gall stone dissolution.
    Jazrawi RP; Pigozzi MG; Galatola G; Lanzini A; Northfield TC
    Gut; 1992 Mar; 33(3):381-6. PubMed ID: 1568660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.